Ottawa, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The global multiple modalities in oncology market is advancing rapidly, with revenues expected to reach hundreds of millions between 2025 and 2034. This ...

In intensive care units, some patients who appear unconscious occupy a gray zone in their relationship to the world. To ...

Oral presentation shares head-to-head results for investigational combination pozelimab plus cemdisiran vs. ravulizumab in paroxysmal nocturnal hemoglobinuria Initial results for odronextamab in first ...

(MENAFN- GlobeNewsWire - Nasdaq) The growth of the multiple modalities in oncology market is driven by the growing incidence of cancer and advances in precision medicine and diagnostics, reports ...

Additional oral presentations explore odronextamab in areas of high unmet need, including the primary analysis in diffuse large B-cell lymphoma progressing after CAR-T therapy and first results in ...

Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to ...

Optically guided surgical approach and the outcome of early-stage oral cancers. Background: We started a prospective cohort study in August 2003 to evaluate the utility of whole- body cancer screening ...